3 ASX Penny Stocks With Market Caps Under A$7B To Watch

In This Article:

As the ASX 200 faces a potential dip, influenced by global economic shifts and local developments, investors are closely monitoring market movements. For those exploring opportunities beyond the established giants, penny stocks—despite their somewhat outdated name—continue to offer intriguing possibilities. These smaller or newer companies can present hidden value when backed by strong financials, providing a chance for significant returns in today's complex market landscape.

Top 10 Penny Stocks In Australia

Name

Share Price

Market Cap

Financial Health Rating

Embark Early Education (ASX:EVO)

A$0.785

A$144.03M

★★★★☆☆

LaserBond (ASX:LBL)

A$0.58

A$67.99M

★★★★★★

SHAPE Australia (ASX:SHA)

A$2.84

A$235.47M

★★★★★★

Helloworld Travel (ASX:HLO)

A$2.01

A$327.26M

★★★★★★

Austin Engineering (ASX:ANG)

A$0.52

A$322.48M

★★★★★☆

MaxiPARTS (ASX:MXI)

A$1.75

A$96.8M

★★★★★★

Navigator Global Investments (ASX:NGI)

A$1.62

A$793.93M

★★★★★☆

EZZ Life Science Holdings (ASX:EZZ)

A$2.64

A$121.86M

★★★★★★

Vita Life Sciences (ASX:VLS)

A$1.97

A$110.79M

★★★★★★

Servcorp (ASX:SRV)

A$4.97

A$490.37M

★★★★☆☆

Click here to see the full list of 1,047 stocks from our ASX Penny Stocks screener.

Here's a peek at a few of the choices from the screener.

Harvey Norman Holdings

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Harvey Norman Holdings Limited operates in the integrated retail, franchise, property, and digital system sectors with a market capitalization of A$6.02 billion.

Operations: The company's revenue segments include Retail in New Zealand (A$952.69 million), Slovenia & Croatia (A$215.44 million), Singapore & Malaysia (A$707.72 million), Non-Franchised Retail (A$242.39 million), and Ireland & Northern Ireland (A$693.42 million).

Market Cap: A$6.02B

Harvey Norman Holdings, with a market cap of A$6.02 billion, is not typically categorized as a penny stock but offers insights into investment considerations. The company's operating cash flow adequately covers its debt (72.7%), and interest payments are well-covered by EBIT (11.1x). Despite trading at 34.7% below estimated fair value and having high-quality earnings, it faces challenges like declining profit margins and negative earnings growth over the past year (-34.7%). Short-term assets exceed short-term liabilities, though long-term liabilities remain uncovered by short-term assets (A$1.8B vs A$2.6B). Recent events include an extension of its buyback plan until November 2025.